<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="HCDDDBD11B9E84809968FF30FDA5639DD" public-private="public" key="H" bill-type="olc">
<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>119 HR 4184 IH: To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes.</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2025-06-26</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code>
<congress display="yes">119th CONGRESS</congress><session display="yes">1st Session</session>
<legis-num display="yes">H. R. 4184</legis-num>
<current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber>
<action display="yes">
<action-date date="20250626">June 26, 2025</action-date>
<action-desc><sponsor name-id="K000376">Mr. Kelly of Pennsylvania</sponsor> (for himself and <cosponsor name-id="H001085">Ms. Houlahan</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HWM00">Committee on Ways and Means</committee-name></action-desc>
</action>
<legis-type>A BILL</legis-type>
<official-title display="yes">To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes.</official-title>
</form>
<legis-body id="HBFA9ED30EFAD4FB2A7982688EE80BE09" style="OLC"> 
<section id="HC04FE641836E441D9BEE248FD7CC716C" section-type="section-one"><enum>1.</enum><header>Exclusion of compensation provided to participants in clinical trials</header> 
<subsection id="H42D39D3E4E45492B9CDD4F8CE8AE4651" display-inline="no-display-inline"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">Part III of subchapter B of <external-xref legal-doc="usc-chapter" parsable-cite="usc-chapter/26/1">chapter 1</external-xref> of the Internal Revenue Code of 1986 is amended by inserting after section 139I the following new section:</text> <quoted-block style="OLC" display-inline="no-display-inline" id="HC112FEAD77F4416CA8B7D760AF16FDD8"> <section id="HB59DCF61907B46C5A5F555E5DB580A6B"><enum>139J.</enum><header>Clinical trial payments</header> <subsection id="H4E1407CC38B84B2C9818A8174B7A9B12"><enum>(a)</enum><header>In general</header><text>Gross income shall not include any amount received by an individual as a qualified clinical trial payment.</text></subsection> 
<subsection id="HF027B1E2FE27470F81A0CAEE4EB9156A"><enum>(b)</enum><header>Qualified clinical trial payment defined</header><text>For purposes of this section, the term <quote>qualified clinical trial payment</quote> means any amount paid to an individual—</text> <paragraph id="HA2BC47980C07435FBC1DD9EDDDA94457"><enum>(1)</enum><text>as compensation for participation by the individual or a dependent of the individual in an approved clinical trial, or </text></paragraph> 
<paragraph id="HC7B6AFE5C65C42DDA64AE6FB4FA889AA"><enum>(2)</enum><text>to reimburse or pay reasonable and necessary expenses incurred in connection with participation by the individual or a dependent of the individual in an approved clinical trial.</text></paragraph></subsection> <subsection id="H9C8BFE4E8BAF40D1BA057F30C0162CC5"><enum>(c)</enum><header>Other definitions</header><text>For purposes of this section—</text> 
<paragraph id="H7B6D71EC071D402B9F008D62BF0A94AD"><enum>(1)</enum><header>Approved clinical trial</header><text display-inline="yes-display-inline">The term <quote>approved clinical trial</quote> has the meaning given such term in section 2709(d)(1) of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/300gg-8">42 U.S.C. 300gg–8(d)(1)</external-xref>), determined by applying <quote>disease or condition</quote> for <quote>life-threatening disease or condition</quote>.</text></paragraph> <paragraph id="H9F2D24D5F318488B9F42828DF3EA55A6"><enum>(2)</enum><header>Dependent</header><text>The term <quote>dependent</quote> has the meaning given such term in section 152. </text></paragraph></subsection></section><after-quoted-block>.</after-quoted-block></quoted-block></subsection> 
<subsection id="H2D207E1335E14AC781D06A00F1F800B5"><enum>(b)</enum><header>Clerical amendment</header><text>The table of sections for part III of subchapter B of chapter 1 of such Code is amended by inserting after the item relating to section 139I the following new item:</text> <quoted-block style="OLC" display-inline="no-display-inline" id="HB9618E1767D34B03800379C9F2E4849D"> <toc container-level="quoted-block-container" quoted-block="no-quoted-block" lowest-level="section" regeneration="yes-regeneration" lowest-bolded-level="division-lowest-bolded"> <toc-entry level="section">Sec. 139J. Clinical trial payments.</toc-entry></toc><after-quoted-block>.</after-quoted-block></quoted-block></subsection> <subsection id="HA46F2140E0CA414D94551885A6DA6D6B"><enum>(c)</enum><header>Effective date</header><text display-inline="yes-display-inline">The amendment made by this section shall apply to amounts paid after December 31, 2025.</text></subsection></section> 
<section id="H0658BF5AA957487EBFD54F9EAF43C636"><enum>2.</enum><header>Clinical trial compensation not taken into account for purposes of determining eligibility for Federal programs or assistance</header> 
<subsection id="HD064F24EA1664ACDAB9BB8D2D459D3B9"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">Notwithstanding any other provision of law, any amount received by an individual as a qualified clinical trial payment shall not be taken into account as income or resources for purposes of determining the eligibility of such individual (or any other individual) for benefits or assistance (or the amount or extent of benefits or assistance) under any Federal program or under any State or local program financed in whole or in part with Federal funds.</text></subsection> <subsection id="H7E19F48E26A4443386B7590B2C6E4193"><enum>(b)</enum><header>Qualified clinical trial payment</header><text display-inline="yes-display-inline">For purposes of subsection (a), the term <quote>qualified clinical trial payment</quote> has the meaning given such term in <external-xref legal-doc="usc" parsable-cite="usc/26/139J">section 139J(a)</external-xref> of the Internal Revenue Code of 1986 (as added by section 1 of this Act). </text></subsection></section> 
</legis-body>
</bill> 


